Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 30, 2023
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
Ami Fadia Reiterated (AVDL) at Strong Buy with Increased Target to $18 on, May 30th, 2023
Ami Fadia of Needham, Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $14 to $18 on, May 30th, 2023.
Ami has made no other calls on AVDL in the last 4 months.
There are 4 other peers that have a rating on AVDL. Out of the 4 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Ami
- Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $22 on, Tuesday, May 2nd, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $16 on, Tuesday, May 2nd, 2023
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 2nd, 2023
- Patrick Dolezal of "LifeSci Capital" Maintained at Buy with Increased Target to $26 on, Tuesday, May 2nd, 2023
